MENU
+Compare
EKSO
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$5.47
Change
+$0.16 (+3.01%)
Capitalization
14.35M

EKSO Ekso Bionics Holdings Inc Forecast, Technical & Fundamental Analysis

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets... Show more

EKSO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EKSO with price predictions
Dec 24, 2025

EKSO in upward trend: 10-day moving average moved above 50-day moving average on December 22, 2025

The 10-day moving average for EKSO crossed bullishly above the 50-day moving average on December 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2025. You may want to consider a long position or call options on EKSO as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EKSO just turned positive on December 08, 2025. Looking at past instances where EKSO's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

EKSO moved above its 50-day moving average on December 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for EKSO moved above the 200-day moving average on December 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EKSO advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EKSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EKSO broke above its upper Bollinger Band on December 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EKSO entered a downward trend on December 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EKSO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.483) is normal, around the industry mean (9.534). P/E Ratio (0.000) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.546). EKSO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.755) is also within normal values, averaging (112.419).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EKSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
EKSO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a robotic exoskeleton company, which designs and develops exoskeletons and wearable robots

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glacier Point
Phone
+1 510 984-1761
Employees
73
Web
https://www.eksobionics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUO1.720.06
+3.61%
Fangdd Network Group Ltd
NXDR2.180.03
+1.40%
Nextdoor Holdings Inc
SYY74.250.26
+0.35%
Sysco Corp
HNVR23.52N/A
N/A
Hanover Bancorp
MGY21.80-0.09
-0.41%
Magnolia Oil & Gas Corp

EKSO and Stocks

Correlation & Price change

A.I.dvisor tells us that EKSO and MBOT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+0.76%
MBOT - EKSO
26%
Poorly correlated
-0.46%
ATEC - EKSO
25%
Poorly correlated
+1.45%
NMTC - EKSO
24%
Poorly correlated
-10.93%
TMDX - EKSO
24%
Poorly correlated
-0.89%
RVP - EKSO
24%
Poorly correlated
+0.01%
More

Groups containing EKSO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+0.76%
Pharmaceuticals
category (375 stocks)
19%
Poorly correlated
+0.29%
Pharmaceuticals: Other
category (102 stocks)
14%
Poorly correlated
+0.21%